An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Zhejiang University
University of Nebraska
ProgenaBiome
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Fox Chase Cancer Center
Swiss Cancer Institute
Stanford University
M.D. Anderson Cancer Center